We haven't heard any more regarding the graphic in your post which states that Fuji will be starting P2 GvHD trials in late 2020.
I thought we may have had some feedback by now on ethics approval, trial approvals etc. for this trial. I have a theory now, that they are waiting on the MSB GvHD FDA approval (or not), before committing to a trial procedure. Any issues found by the FDA could be addressed in a tailored trial which addresses any questions raised.
It would be great to go head to head with an identical trial against the MSB technology. I was hoping this would be achieved with the COVID trial, but it would seem we limited ourselves geographically on this front.
We haven't heard any more regarding the graphic in your post...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |